Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AmerisourceBergen Opens Its Books To Manufacturers In Contract Talks

This article was originally published in The Pink Sheet Daily

Executive Summary

"Manufacturers have lost track of the real value" wholesalers add to the channel, CEO Yost says. McKesson and Cardinal may also offer transparency in fee-for-service negotiations, Yost speculates.

You may also be interested in...



ABC Still Optimistic On Fee-For-Service Despite Dropping Earnings Estimates

AmerisourceBergen still aims to have most manufacturers under fee-for-service agreements by the end of 2005. Although ABC has not set a March 31 deadline for fee-for-service contracts like Cardinal and McKesson, CEO Yost says "there is nothing in the market place that would imply that we are slower" at making the transition.

ABC Still Optimistic On Fee-For-Service Despite Dropping Earnings Estimates

AmerisourceBergen still aims to have most manufacturers under fee-for-service agreements by the end of 2005. Although ABC has not set a March 31 deadline for fee-for-service contracts like Cardinal and McKesson, CEO Yost says "there is nothing in the market place that would imply that we are slower" at making the transition.

COX-2 Woes’ Impact On Wholesaler Revenues Are Minimal, ABC Claims

AmerisourceBergen would lose about 1% of revenues if all COX-2 inhibitors were withdrawn from the market, CEO David Yost said Jan. 25

Related Content

Topics

UsernamePublicRestriction

Register

PS060940

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel